These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 29764807)

  • 1. Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
    Yap T; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; Seers C; McCullough M
    Cancer Prev Res (Phila); 2018 Aug; 11(8):491-502. PubMed ID: 29764807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
    Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
    Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders.
    Yap T; Seers C; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; McCullough M
    Oral Oncol; 2019 Sep; 96():113-120. PubMed ID: 31422202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A circulating microRNA panel as a novel dynamic monitor for oral squamous cell carcinoma.
    Piao Y; Jung SN; Lim MA; Oh C; Jin YL; Kim HJ; Nguyen QK; Chang JW; Won HR; Koo BS
    Sci Rep; 2023 Feb; 13(1):2000. PubMed ID: 36737651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
    Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.
    Yao LX; Liu J; Xu L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):187-197. PubMed ID: 30657560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
    Ji L; Zhu ZN; He CJ; Shen X
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
    Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
    J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.
    Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
    Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A panel of microRNAs can be used to determine oral squamous cell carcinoma.
    Prasad G; Seers C; Reynolds E; McCullough MJ
    J Oral Pathol Med; 2017 Nov; 46(10):940-948. PubMed ID: 28512746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
    Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of miRNA-196a and miRNA-196b correlates with Bryne's prognostic score in oral squamous cell carcinoma.
    Singh K; Urs AB; Koner BC; Augustine J; Shrivastava R; Narayan B
    Pathol Res Pract; 2024 Jan; 253():154954. PubMed ID: 38039741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.
    Zhang XJ; Jin Y; Song JL; Deng F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5270-5276. PubMed ID: 31298378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
    Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
    J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
    Liu Y; Li R; Ren G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.